Abstract: This paper proposes an e-commerce user portrait construction algorithm based on big data technology, combining deep learning and cluster analysis, and realizing accurate portrait ...

Google has rolled out fewer confirmed search ranking updates in 2025, then it did in all the past years where Google confirmed these updates. Google rolled out only four confirmed updates in 2025, ...

Google launched four official and confirmed algorithmic updates in 2025, three core updates and one spam update. This is in comparison to last year, in 2024, where we had seven confirmed updates, then ...

We introduce VeriStruct, a novel framework that extends AI-assisted automated verification from single functions to more complex data structure modules in Verus. VeriStruct employs a planner module to ...

Structure Therapeutics’ stock soared toward an 18-month high in early Monday trading, after mid-stage data for its oral daily GLP-1 receptor appeared comparable to that of one of Eli Lilly’s ...

This repository contains solution code files for the "Data Structure and Algorithm - I Lab" course as provided on the CodeTantra platform by Noida Institute of Engineering and Technology. The files ...

When Edsger W. Dijkstra published his algorithm in 1959, computer networks were barely a thing. The algorithm in question found the shortest path between any two nodes on a graph, with a variant ...

Ben Khalesi writes about where artificial intelligence, consumer tech, and everyday technology intersect for Android Police. With a background in AI and Data Science, he’s great at turning geek speak ...

As aid organizations turn to artificial intelligence to optimize resources, a Rutgers expert reports on a new targeting approach that puts people first When the COVID-19 pandemic hit, aid ...

SAN FRANCISCO, Oct 22 (Reuters) - Google said it has developed a computer algorithm that points the way to practical applications for quantum computing and will be able to generate unique data for use ...

Structure Therapeutics Inc. is a clinical-stage biotech focused on oral GLP-1 drugs for obesity, targeting a rapidly growing sector in pharma market. GPCR's valuation appears attractive given a $1B ...